March 25 (Reuters) - A bipartisan group of U.S. senators

has reached a deal on capping the price of a month's supply of

insulin at $35, Semafor reported on Wednesday, citing an

interview with New Hampshire Democrat Senator Jeanne Shaheen.

Shaheen is making an urgent push to pass legislation to

reduce the cost of insulin before her retirement from Congress,

teaming with Senators Susan Collins, Raphael Warnock and John

Kennedy, according to the Semafor report.